While tumor diameter, nodal status and MUC-1 expression were similar in the two groups, the group exhibiting five immune markers contained higher HLA-DR contents (p < 0.0001) and CXCL13 expression levels (p = 0.001) than those with none of the selected markers. This evidence concerns the gene CXCL13 and neoplasm.